17-O-METHYL-TERPESTACIN
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2sVB2CVUQIz |
|---|---|
| InChI | InChI=1S/C26H40O4/c1-17-8-7-9-18(2)14-15-26(5)21(12-11-19(3)22(28)13-10-17)23(20(4)16-27)24(30-6)25(26)29/h8,11,14,20-22,27-28H,7,9-10,12-13,15-16H2,1-6H3/b17-8-,18-14-,19-11-/t20-,21-,22+,26+/m0/s1 |
| InChIKey | GTPZCNNJOBQDGU-SOBZSXSDSA-N |
| Mol Weight | 416.6 g/mol |
| Molecular Formula | C26H40O4 |
| Exact Mass | 416.29266 g/mol |
| Enantiomer InChIKey | GTPZCNNJOBQDGU-APXBLPLCSA-N |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
FUSAPROLIFERIN;18-[1-(ACETOXYMETHYL)-2-METHYLETHYL]-10,17-DIHYDROXY-3,7,11,15-TETRAMETHYLBICYCLO-[13.3.0]-OCTADECA-TRANS,TRANS,TRANS,CIS-2,6,11,17
10-Isopropyl-3,7-dimethyl-8-oxohexahydro-1H-azeluene-5-ol 4-Methoxybenzoate
1(S)-Dimethylamino-2,3-diethyl-(endo)-6-hydroxybicyclo[3.3.0]oct-2-en-4-one
Cycloprop[a]indene-5-propanoic acid, 1,1a,1b,2,3,4,6,6a-octahydro-1b-methyl-6a-(1-methylethyl)-4-oxo-, [1aS-(1a.alpha.,1b.beta.,6a.alpha.)]-
(+/-)-2-(1S,2S,5R)-(2-(2-Ethoxypropan-2-yl)-5-methylcyclopentyl)-3,6-dihydroxy-5-undecylcyclohexa-2,5-diene-1,4-dione
(1S,2S,4S,5S)-bis-(3H-isobenzofuran-1-ylidene)-bicyclo[2.2.1]heptane-2,5-diamine
3H-Naphtho[2,3-b]furan-2-one, 5,8a-dimethyl-3-[(1-phenylethylamino)methyl]-3a,7,8,8a,9,9a-hexahydro-
ACCCXKJYFXCKNE-UHFFFAOYSA-N
Dimethyl (3aS,7aR)-7-hydroxy-2,5-dimethyl-3a,4,5,7a-tetrahydro-1-benzofuran-3,6-dicarboxylate
CRYPTOPORIC-ACID-I-TRIMETHYLESTER
| Title | Journal or Book | Year |
|---|---|---|
| Stereochemistry and biosynthesis of terpestacin, a new syncytium formation inhibitor | The Journal of Organic Chemistry | 1993 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.